Guest guest Posted November 7, 2007 Report Share Posted November 7, 2007 Semin Liver Dis 2007; 27: 413-426DOI: 10.1055/s-2007-991517 Hepatic Fibrogenesis Jinsheng Guo1,2, L. Friedman1 1 Division of Liver Diseases, Mount Sinai Hospital, Mount Sinai School of Medicine, New York, New York2 Division of Digestive Diseases, Zhongshan Hospital, Department of Internal Medicine, Shanghai Medical College, Fudan University, Shanghai, China ABSTRACT Hepatic fibrogenesis represents a wound-healing response of liver to a variety of insults, ultimately leading to decompensated cirrhosis in many patients and accounting for extensive morbidity and mortality worldwide. The net accumulation of extracellular matrix (ECM) in liver injury arises from increased synthesis by activated hepatic stellate cells and other hepatic fibrogenic cell types, as well as from bone marrow and circulating fibrocytes. Concurrently, degradation of ECM by matrix metalloproteinases (MMPs) fails to keep pace with increased synthesis, in part due to sustained expression of MMP inhibitors (e.g., tissue inhibitors of metalloproteinases). A growing list of circulating, paracrine, and autocrine mediators have been identified that amplify the fibrogenic response of liver. Combined with accelerating knowledge about signaling pathways and genetic determinants, major advances are anticipated in new diagnostics and therapies that will transform the care of patients with chronic liver diseases in the coming years. KEYWORDS Hepatic fibrogenesis - extracellular matrix - hepatic stellate cells - tissue inhibitors of metalloproteinases - signaling pathways Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.